fbpx
Wikipedia

False neurotransmitter

A false neurotransmitter is a chemical compound which closely imitates the action of a neurotransmitter in the nervous system. Examples include 5-MeO-αMT (mimicking serotonin) and α-methyldopa.

These chemicals can be accumulated by a neuron or secretory cell, are then packaged in secretory / synaptic vesicles, and then released with other neurotransmitters when an action potential provides the necessary stimulus for release.[1]

The concept of a false transmitter is credited to Irwin Kopin of the National Institute of Neurological Disorders and Stroke who determined that the drug tyramine increased blood pressure by being loaded and then released from secretory vesicles of the adrenal chromaffin cells. Tyramine can also be converted into octopamine by the dopamine-beta-hydroxylase (DBH) which itself acts as a false transmitter by displacing noradrenaline from its vesicle but not activating the postsynaptic alpha adrenoreceptor.

There is growing evidence that a large number of well known exogenous chemicals work as substitute neurotransmitters, though the distinction between the classical model and the substitute neurotransmitter model only becomes apparent with neurotransmitters central to the signaling in the conscious brain, like dopamine and serotonin (as mentioned above). By extension, drugs that affect the uptake affinity of neurotransmitter transporters directly affect the efficacy of these substitute neurotransmitters, as shown by the interference that selective serotonin reuptake inhibitors have on serotonergic psychedelic drugs.

A family of fluorescent false neurotransmitters have been developed by Dalibor Sames and David Sulzer at Columbia University that act as analogs for dopamine and other monoamines and enable an optical means for video analysis of neurotransmitter uptake and release.[2]

References edit

  1. ^ "inta, 2018-V2-61-67.pdf". doi:10.35486/at.v12i1.40.g27. {{cite journal}}: Cite journal requires |journal= (help) (downloads)
  2. ^ Gubernator, N. G.; Zhang, H.; Staal, R. G. W.; Mosharov, E. V.; Pereira, D. B.; Yue, M.; Balsanek, V.; Vadola, P. A.; Mukherjee, B.; Edwards, R. H.; Sulzer, D.; Sames, D. (2009). "Fluorescent False Neurotransmitters Visualize Dopamine Release from Individual Presynaptic Terminals". Science. 324 (5933): 1441–1444. Bibcode:2009Sci...324.1441G. CiteSeerX 10.1.1.666.7423. doi:10.1126/science.1172278. PMC 6696931. PMID 19423778.


false, neurotransmitter, false, neurotransmitter, chemical, compound, which, closely, imitates, action, neurotransmitter, nervous, system, examples, include, αmt, mimicking, serotonin, methyldopa, these, chemicals, accumulated, neuron, secretory, cell, then, p. A false neurotransmitter is a chemical compound which closely imitates the action of a neurotransmitter in the nervous system Examples include 5 MeO aMT mimicking serotonin and a methyldopa These chemicals can be accumulated by a neuron or secretory cell are then packaged in secretory synaptic vesicles and then released with other neurotransmitters when an action potential provides the necessary stimulus for release 1 The concept of a false transmitter is credited to Irwin Kopin of the National Institute of Neurological Disorders and Stroke who determined that the drug tyramine increased blood pressure by being loaded and then released from secretory vesicles of the adrenal chromaffin cells Tyramine can also be converted into octopamine by the dopamine beta hydroxylase DBH which itself acts as a false transmitter by displacing noradrenaline from its vesicle but not activating the postsynaptic alpha adrenoreceptor There is growing evidence that a large number of well known exogenous chemicals work as substitute neurotransmitters though the distinction between the classical model and the substitute neurotransmitter model only becomes apparent with neurotransmitters central to the signaling in the conscious brain like dopamine and serotonin as mentioned above By extension drugs that affect the uptake affinity of neurotransmitter transporters directly affect the efficacy of these substitute neurotransmitters as shown by the interference that selective serotonin reuptake inhibitors have on serotonergic psychedelic drugs A family of fluorescent false neurotransmitters have been developed by Dalibor Sames and David Sulzer at Columbia University that act as analogs for dopamine and other monoamines and enable an optical means for video analysis of neurotransmitter uptake and release 2 References edit inta 2018 V2 61 67 pdf doi 10 35486 at v12i1 40 g27 a href Template Cite journal html title Template Cite journal cite journal a Cite journal requires journal help downloads Gubernator N G Zhang H Staal R G W Mosharov E V Pereira D B Yue M Balsanek V Vadola P A Mukherjee B Edwards R H Sulzer D Sames D 2009 Fluorescent False Neurotransmitters Visualize Dopamine Release from Individual Presynaptic Terminals Science 324 5933 1441 1444 Bibcode 2009Sci 324 1441G CiteSeerX 10 1 1 666 7423 doi 10 1126 science 1172278 PMC 6696931 PMID 19423778 nbsp This drug article relating to the nervous system is a stub You can help Wikipedia by expanding it vte Retrieved from https en wikipedia org w index php title False neurotransmitter amp oldid 1136394622, wikipedia, wiki, book, books, library,

article

, read, download, free, free download, mp3, video, mp4, 3gp, jpg, jpeg, gif, png, picture, music, song, movie, book, game, games.